MoneyWorks4Me

RBI increases FII investment limit in Natco Pharma to 49%

16 May 2017 Evaluate

Reserve Bank of India has notified that Foreign Institutional Investors (FIIs)/Foreign Portfolios Investors (FPIs) can now invest up to 49% of the paid up capital of Natco Pharma under the Portfolio Investment Scheme (PIS).

The company has already passed resolutions at its Board of Directors’ level and a special resolution by general body agreeing for enhancing the FII/FPI investment limit under Portfolio Investment Scheme from 31.50% to 49% of the paid up capital of the company.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..